Purification of Fluorescent Protein-Labeled Antibodies by Gel Filtration Chromatography

Applications | 2026 | ShimadzuInstrumentation
HPLC, GPC/SEC
Industries
Pharma & Biopharma
Manufacturer
Shimadzu

Summary

Purification of Fluorescent Protein-Labeled Antibodies by Gel Filtration Chromatography — Summary


Significance of the Topic


Fluorescently labeled antibodies are essential reagents in flow cytometry, immunofluorescence and other bioassays. Labels based on fluorescent proteins such as R-phycoerythrin (R-PE) provide much higher brightness than small-molecule dyes, improving sensitivity for low-abundance antigens. However, incomplete removal of unreacted label elevates background signal and reduces assay performance. Robust, high-resolution purification methods that allow real-time monitoring of both labeled and unlabeled antibody fractions are therefore valuable for producing high-quality reagents for research and diagnostics.

Objectives and Study Overview


This application study demonstrated purification of R-PE-labeled mouse monoclonal IgG by gel filtration chromatography (GFC) using a corrosion-resistant, low-pressure-capable LC platform. Main aims were:
  • Separate and fractionate R-PE-labeled IgG, excess free R-PE and unlabeled IgG.
  • Enable simultaneous monitoring by fluorescence and UV (PDA) detectors for reliable fraction collection.
  • Show compatibility with agarose gel columns and high-salt mobile phases thanks to an inert (metal-free) LC flow path.

Methodology


Sample preparation and labeling
  • 100 µg mouse monoclonal IgG labeled with SH-reactive R-PE (maleimide chemistry) targeting reduced hinge-region thiols; resulting mixture contained labeled IgG, unlabeled IgG and excess R-PE.
  • Prior to injection, labeled IgG solution was diluted tenfold in mobile phase.

Chromatography and detection
  • System: Nexera lite inert LC configured with fluorescence detector (RF-20Axs), photodiode array detector (SPD-M40) and fraction collector (FRC-10A). PDA signal triggered fraction collection.
  • Column: Gel filtration column for proteins (300 mm × 10 mm I.D., 8.6 µm; fractionation range ~10,000–600,000 Da).
  • Mobile phase: 0.1 M sodium phosphate buffer pH 6.8 with 0.2 M NaCl.
  • Flow rate: 0.5 mL/min; injection volume: 100 µL; ambient temperature.
  • Detection: Fluorescence Ex 564 nm / Em 575 nm (gain ×4, low sensitivity) and PDA at 280 nm.
  • Calibration: Protein standards (molecular weights range ~13,700–440,000 Da) were run to generate a log(Mw) vs retention time calibration curve using LabSolutions GPC software.

Used Instrumentation


Instrumentation and key components used in the study included:
  • Nexera lite inert HPLC system with corrosion-resistant (metal-free) fluid path.
  • Fluorescence detector RF-20Axs (flow cell optimized for inert LC).
  • Photodiode array detector SPD-M40 with enlarged flow cell to reduce back pressure.
  • Fraction collector FRC-10A and low-pressure-compatible gel filtration column (agarose packing).
  • Shim-vial H glass vials (0.15 mL) for small-volume sample handling.

Main Results and Discussion


Chromatographic separation produced three distinct peaks detected by PDA and fluorescence detectors:
  • Peak 1 — assigned to R-PE-labeled IgG: eluted earliest and exhibited the highest apparent molecular weight (estimated 270,000–700,000 Da based on calibration), consistent with the conjugation of ~250 kDa R-PE to ~150 kDa IgG forming larger species or aggregates.
  • Peak 2 — excess free R-PE: estimated ~200,000 Da, observed by both detectors but prominent in fluorescence signal.
  • Peak 3 — unlabeled IgG: eluted later at an apparent molecular weight ~140,000 Da and was detected primarily by PDA at 280 nm.

Key performance observations:
  • Simultaneous fluorescence and UV monitoring allowed clear discrimination of fluorescently labeled species from non-fluorescent protein.
  • The high-sensitivity fluorescence detector detected IgG quantities down to the low-microgram range (maximum injected ~7 µg IgG in this study), enabling fractionation of trace-level samples.
  • Use of an inert, metal-free LC flow path maintained stability and signal quality in a mobile phase containing relatively high salt (0.2 M NaCl).
  • Enlarged flow cells and low back-pressure architecture permitted the use of low- to medium-pressure agarose gel columns, broadening column choices for protein purification.

Benefits and Practical Applications


This approach provides practical advantages for laboratories preparing fluorescent protein–labeled antibodies:
  • Efficient removal of excess fluorescent protein reduces background and improves signal-to-noise in downstream assays.
  • Real-time dual-detection (fluorescence + PDA) simplifies decision-making for fraction collection and improves reliability of collected fractions.
  • Compatibility with agarose gel filtration columns supports gentle separation of protein conjugates and aggregates, minimizing shear and preserving biological activity.
  • Small-volume fractionation (microtubes, 96-well plates) facilitates processing of limited or multiple samples and integration into workflows for reagent preparation or QC.

Future Trends and Potential Applications


Potential directions to extend and apply this methodology include:
  • Automation and scale-up: integrate multi-column switching and automated fraction handling for higher throughput reagent production.
  • Orthogonal purification strategies: combine GFC with affinity or ion-exchange steps to fine-tune removal of aggregates or unconjugated label.
  • Labeling analytics: couple fractionation to advanced detectors (e.g., light-scattering, native MS) to better characterize conjugation stoichiometry and aggregation state.
  • Broader label types: adapt the workflow for other fluorescent proteins and tandem-label constructs used in multiplexed assays.
  • Miniaturization and microfluidics: develop lower-volume GFC formats for precious samples and rapid QC checks.

Conclusion


Gel filtration chromatography performed on an inert, low-pressure-capable LC system enables effective purification and fractionation of R-PE-labeled IgG. Dual detection by fluorescence and PDA provides sensitive, real-time monitoring that distinguishes labeled species, free label and unlabeled antibody, supporting reliable collection of purified fractions. The corrosion-resistant flow path and reduced back pressure allow use of agarose gel columns and high-salt mobile phases, making the method broadly applicable for preparing high-quality fluorescent protein–labeled antibodies for research and assay development.

References


  • Shimadzu Corporation. Purification of Fluorescent Protein-Labeled Antibodies by Gel Filtration Chromatography. Application news (01-00993-EN), First Edition Mar 2026.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Evaluation of Membrane Protein Properties by Fluorescence-Detection Size-Exclusion Chromatography (FSEC) Using an NexeraTMlite inert system
Application Note Evaluation of Membrane Protein Properties by Fluorescence-Detection Size-Exclusion Chromatography (FSEC) Using an NexeraTM lite inert system Emiko Ando1、Hidetoshi Terada1 Life Science Life Science  Abstract However, when membrane proteins are transiently expressed using cultured cells, in many cases,…
Key words
membrane, membranegfp, gfpfluorescence, fluorescencefsec, fsecprotein, proteinexpression, expressionsolubilization, solubilizationproteins, proteinspellet, pelletcell, cellunpurified, unpurifiedevaluation, evaluationinquiry, inquirycells, cellsgel
A Study on a Method for Evaluating Glycans in Biopharmaceuticals - Part 2 – Comparison of various pretreatment methods for N-Glycan Analysis –
LAAN-A-TM-E050 Application News No. B79 MALDI-TOF Mass Spectrometry A Study on a Method for Evaluating Glycans in Biopharmaceuticals - Part 2 – Comparison of various pretreatment methods for N-Glycan Analysis – Many protein-based biopharmaceutical products are synthesized in cultured cells…
Key words
glycan, glycanglycans, glycanspurification, purificationcomparison, comparisonphase, phaseareas, areascentrifugal, centrifugalprocedure, procedurestep, stepevaporator, evaporatorderivatized, derivatizedsolid, solidsolution, solutionpretreatment, pretreatmentderivatization
BIOSEPARATIONS - APPLICATIONS NOTEBOOK
MAIN MENU TABLE OF CONTENTS [ APPLICATIONS NOTEBOOK ] BIOSEPARATIONS Tools, Techniques, and Insights into Biopharmaceutical Analysis INT RODUCTION Biopharmaceuticals have emerged as a dominant class due to their specificity and efficacy. T he production of biopharmaceuticals, however, is distinctly…
Key words
menu, menuuplc, uplcglycan, glycanmain, mainacquity, acquitycontents, contentsrapifluor, rapifluorglycans, glycanstable, tablehilic, hilicclass, classseparations, separationsbio, bioblend, blendglycoworks
Agilent Biocolumns - Glycan Analysis - Application Compendium
Agilent Biocolumns Glycan Analysis Application Compendium Contents Background 2 Getting Started 3 How to Guide - Glycan Mapping 4 Featured Application Notes 1 16 Streamlined Workflows for N-Glycan Analysis of Biotherapeutics Using Agilent AdvanceBio Gly-X InstantPC and 2-AB Express Sample…
Key words
glycan, glycanreturn, returnglycans, glycanssection, sectioncontents, contentsadvancebio, advancebioinstantpc, instantpcsialic, sialicfld, fldagilent, agilentlabeled, labeledmapping, mappingassaymap, assaymaplinked, linkedbiosimilar
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike